• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA 1939 通过下调 miR-154 抑制人肾细胞癌(RCC)细胞的增殖和迁移。

Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.

机构信息

Department of Urology, The First Affiliated Hospital of Soochow University, Jiangsu, China.

Department of Urology, Jining No, 1 People's Hospital, Jining, China.

出版信息

Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):695-702. doi: 10.1080/21691401.2020.1725024.

DOI:10.1080/21691401.2020.1725024
PMID:32138544
Abstract

Renal carcinoma (RCC) is widely accepted as a malignant tumour of urinary system. Long intergenic non-coding RNA 1939 (LINC01939) is a novel lncRNA which was found to be down-regulated in RCC. Thus, we set out to explore the effect and regulation mechanism of LINC01939 in RCC. LINC01939 and miR-154 in RCC tissues and cell lines were detected using qRT-PCR assay. To examine cellular viability of ACHN and CAKI-1 cells, cell counting kit-8 (CCK-8) assay was exploited here. Flow cytometric analysis was conducted to examine apoptosis. Cell mobility was valued through wound healing assays. Western blotting was applied for examination of proteins related to proliferation, apoptosis, migration and Wnt/β-catenin/Notch. LINC01939 was down-regulated in RCC tissues. LINC01939 overexpression impeded proliferation and migration, and induced apoptosis. Further study found that the overexpression of LINC01939 strongly suppressed miR-154 expression. Then, the inhibiting effect of overexpressed LINC01939 on proliferation and mobility and the promoting role of LINC01939 in apoptosis were abolished by the combination of miR-154 mimic. Finally, we found that overexpressed LINC01939 inactivated Wnt/β-catenin and Notch through suppressing miR-154. Up-regulation of LINC01939 inhibited proliferation and migration of RCC cells by down-regulating miR-154.

摘要

肾细胞癌(RCC)被广泛认为是一种泌尿系统恶性肿瘤。长链非编码 RNA 1939(LINC01939)是一种新型的 lncRNA,在 RCC 中发现下调。因此,我们着手探讨 LINC01939 在 RCC 中的作用和调节机制。采用 qRT-PCR 检测 RCC 组织和细胞系中的 LINC01939 和 miR-154。利用细胞计数试剂盒-8(CCK-8)检测 ACHN 和 CAKI-1 细胞的细胞活力。通过流式细胞术分析检测细胞凋亡。通过划痕愈合实验评估细胞迁移能力。应用 Western blot 检测与增殖、凋亡、迁移和 Wnt/β-catenin/Notch 相关的蛋白。LINC01939 在 RCC 组织中下调。LINC01939 过表达抑制增殖和迁移,并诱导凋亡。进一步研究发现,LINC01939 的过表达强烈抑制 miR-154 的表达。然后,通过 miR-154 模拟物的组合,消除了过表达 LINC01939 对增殖和迁移的抑制作用以及 LINC01939 对凋亡的促进作用。最后,我们发现过表达 LINC01939 通过抑制 miR-154 使 Wnt/β-catenin 和 Notch 失活。LINC01939 的上调通过下调 miR-154 抑制 RCC 细胞的增殖和迁移。

相似文献

1
Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.长链非编码 RNA 1939 通过下调 miR-154 抑制人肾细胞癌(RCC)细胞的增殖和迁移。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):695-702. doi: 10.1080/21691401.2020.1725024.
2
LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.长链非编码 RNA NBAT1 通过 miR-346/GSK-3β 轴抑制肾细胞癌中的细胞增殖和迁移。
IUBMB Life. 2019 Nov;71(11):1720-1728. doi: 10.1002/iub.2111. Epub 2019 Jul 12.
3
Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.长链非编码 RNA 小核仁 RNA 宿主基因 1(SNHG1)通过负向调控 miR-137 促进肾细胞癌的进展和转移。
Med Sci Monit. 2018 Jun 6;24:3824-3831. doi: 10.12659/MSM.910866.
4
Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.长链非编码 RNA DUXAP8 通过下调 miR-126 促进肾细胞癌进展。
Med Sci Monit. 2018 Oct 14;24:7340-7347. doi: 10.12659/MSM.910054.
5
Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.长非编码 RNA LOXL1-AS1 通过海绵吸附 miR-589-5p 上调肾细胞癌中 CBX5 的表达。
Biosci Rep. 2020 Nov 27;40(11). doi: 10.1042/BSR20200212.
6
Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.长链非编码 RNA MALAT1 通过靶向 miR-22-3p 调控 PI3K/Akt 通路影响肾透明细胞癌细胞活力和迁移。
Oncol Rep. 2019 Feb;41(2):1113-1121. doi: 10.3892/or.2018.6853. Epub 2018 Nov 6.
7
Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.探讨长链非编码 RNA MEG3 通过调控 miR-7/RASL11B 信号通路影响肾透明细胞癌的作用机制。
J Cell Physiol. 2018 Dec;233(12):9503-9515. doi: 10.1002/jcp.26849. Epub 2018 Jul 3.
8
Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.长链非编码 RNA MALAT1 的耗竭通过调节 miR-362-3p 介导的 G3BP1 抑制肾细胞癌中的舒尼替尼耐药。
Cell Cycle. 2020 Aug;19(16):2054-2062. doi: 10.1080/15384101.2020.1792667. Epub 2020 Jul 14.
9
LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.LINC01510 通过抑制肾细胞癌中的 Wnt/β-连环蛋白信号通路来抑制细胞增殖和侵袭。
Biochem Biophys Res Commun. 2018 Oct 20;505(1):7-12. doi: 10.1016/j.bbrc.2018.08.167. Epub 2018 Sep 14.
10
LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR-103a.长链非编码 RNA SNHG1 通过海绵吸附 miR-103a 调控 HMGA2 促进肾细胞癌进展。
J Clin Lab Anal. 2022 Jun;36(6):e24422. doi: 10.1002/jcla.24422. Epub 2022 Apr 25.

引用本文的文献

1
MiR-146b-5p/SEMA3G regulates epithelial-mesenchymal transition in clear cell renal cell carcinoma.微小RNA-146b-5p/信号素3G调控透明细胞肾细胞癌中的上皮-间质转化
Cell Div. 2023 Mar 7;18(1):4. doi: 10.1186/s13008-023-00083-w.
2
A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment.长链非编码RNA与微小RNA网络在肾透明细胞癌及其肿瘤微环境中的作用综述
Cancer Cell Int. 2023 Feb 2;23(1):16. doi: 10.1186/s12935-023-02861-6.
3
The interplay between non-coding RNAs and Wnt/ß-catenin signaling pathway in urinary tract cancers: from tumorigenesis to metastasis.
非编码RNA与Wnt/β-连环蛋白信号通路在泌尿系统癌症中的相互作用:从肿瘤发生到转移
EXCLI J. 2022 Oct 18;21:1273-1284. doi: 10.17179/excli2022-5348. eCollection 2022.